alnylam
The Director, Biostatistics provides leadership and guidance for large and/or complex late phase clinical development programs. The role involves designing innovative clinical trials, authoring statistical sections of protocols, and leading biostatistics support for worldwide regulatory submissions. This position requires interpreting and communicating statistical analysis results to support regulatory filings and scientific manuscripts.
Headquarters
Cambridge, Massachusetts, United States
Company Size
1001-5000 employees
Founded
2002
Alnylam is a biopharmaceutical company that has pioneered RNA interference (RNAi) therapeutics, an innovative class of medicines that treats diseases by silencing the genes that cause or contribute to them. The company develops RNAi-based medicines targeting both rare and prevalent diseases across multiple therapeutic areas, with approved products and a robust investigational pipeline. Driven by science and inspired by patients, Alnylam is committed to delivering transformational medicines that address diseases at their genetic source.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for alnylam.
Associate Director Biostatistics
Integrated Resources INC
Senior Director, Biostatistics
Beeline Medicines
Director of Biostatistics
Treeline Biosciences
Associate Director, Biostatistics
Alnylam Pharmaceuticals
Senior Manager or Associate Director, Biostatistics
Scholar Rock
Senior Manager, Biostatistics
Bristol Myers Squibb